Skip to content

To collect data on cancer treatment, its outcome and epidemiology in pregnant patient having breast cancer

Pregnancy Associated Breast Cancer PABC Registry to collate data on epidemiology and treatment patterns and outcomes of PABC - PABC registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/02/007907
Enrollment
100
Registered
2017-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having Pregnancy associated breast cancer

Interventions

None listed

Sponsors

Roche Products India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with histological confirmed breast cancer who are pregnant Or Patients who got diagnosed within 1 year of last pregnancy with histological confirmed breast cancer Informed consent for data collection (for prospective participants only) For retrospective participants an informed consent is not required as long as the data are anonymously captured

Exclusion criteria

Exclusion criteria: Unwilling to participate Not able to give valid informed consent In retrospective registry where records not available

Design outcomes

Primary

MeasureTime frame
Stage and biological characteristics of breast cancer Breast cancer therapy Sensitivity and specificity of diagnostic procedures palpation USG mammogram Adverse events/side effects in PABC patients receiving chemotherapy compared to non-pregnant young women receiving chemotherapy Outcome of the newborn after therapy Outcome of breast cancer after diagnosis Rate of pregnancies after breast cancer Timepoint: Observational Trial,data will be assessed post completion of target accrual.

Secondary

MeasureTime frame
Observational Trial, for assessing on epidemiology and treatment patterns and outcomes of PABCTimepoint: Data will be assessed post completion of target accrual.;Stage and biological characteristics of breast cancer Breast cancer therapy Sensitivity and specificity of diagnostic procedures palpation USG mammogram Adverse events/side effects in PABC patients receiving chemotherapy compared to non-pregnant young women receiving chemotherapy Outcome of the newborn after therapy Outcome of breast cancer after diagnosis Rate of pregnancies after breast cancer Timepoint: Not applicable as its observational study both prospective and retroprospective

Countries

India

Contacts

Public ContactDr Jyoti Bajpai

Tata Memorial Hospital

dr_jyotibajpai@yahoo.co.in02224177287

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026